Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation.

Conclusion: Allo-HSCT is a useful choice for patients with refractory/relapsed PTCLs or high-risk new diagnosed PTCLs.
PMID: 30127221 [PubMed - in process]

Source: Chinese Medical Journal - August 23, 2018 Category: General Medicine Authors: Huang WR, Liu DH Tags: Chin Med J (Engl) Source Type: research